Activation of astroglial CB1R mediates cerebral ischemic tolerance induced by electroacupuncture. Issue 9 (September 2021)

• Record Type: Journal Article
• Authors: Yang, Cen; Liu, Jingjing; Wang, Jingyi; Yin, Anqi; Jiang, Zhenhua; Ye, Shuwei; Liu, Xue; Zhang, Xia; Wang, Feng; Xiong, Lize
• Is Part Of: Journal of cerebral blood flow & metabolism. Volume 41:Issue 9(2021)
• Page Start: 2295
• Page End: 2310
• Publication Date: 2021-09
• Subjects: Astrocyte -- CB1R -- electroacupuncture -- pretreatment -- stroke; Cerebral circulation -- Periodicals; Brain -- Metabolism -- Periodicals; Brain -- Blood-vessels -- Periodicals; Cerebrovascular disease -- Periodicals; 612.824
• DOI: 10.1177/0271678X21994395
• Languages: English
• ISSNs: 0271-678X

Abstract

There are no effective treatments for stroke. The activation of endogenous protective mechanisms is a promising therapeutic approach, which evokes the intrinsic ability of the brain to protect itself. Accumulated evidence strongly suggests that electroacupuncture (EA) pretreatment induces rapid tolerance to cerebral ischemia. With regard to mechanisms underlying ischemic tolerance induced by EA, many molecules and signaling pathways are involved, such as the endocannabinoid system, although the exact mechanisms have not been fully elucidated. In the current study, we employed mutant mice, neuropharmacology, microdialysis, and virus transfection techniques in a middle cerebral artery occlusion (MCAO) model to explore the cell-specific and brain region-specific mechanisms of EA-induced neuroprotection. EA pretreatment resulted in increased ambient endocannabinoid (eCB) levels and subsequent activation of ischemic penumbral astroglial cannabinoid type 1 receptors (CB1 R) which led to moderate upregulation of extracellular glutamate that protected neurons from cerebral ischemic injury. These findings provide a novel cellular mechanism of EA and a potential therapeutic target for ischemic stroke.